Winners
- Jaguar Health The stock (NASDAQ: JAGX) rose 22.6% to $ 1.14 in Tuesday’s after-sales session. Today’s trade volume for this stock closed at 1.8 million shares, or 56.0% of its average volume over the past 100 days. The market value of their outstanding shares is $ 52.5 million.
- Iridex The stock (NASDAQ: IRIX) rose 4.45% to $ 5.86. The company’s market capitalization is $ 92.9 million.
- Pharmacy Kiora The stock (NASDAQ: KPRX) rose 3.77% to $ 0.97. The company’s market capitalization is $ 12.2 million.
- Qualigen Therapeutics The stock (NASDAQ: QLGN) rose 3.77% to $ 1.1. The market capitalization of the company is $ 38.8 million.
- Tivic health systems (NASDAQ: TIVC) rose 3.21% to $ 3.21. The company’s market capitalization is $ 31.1 million.
- Reshaping the life sciences (NASDAQ: RSLS) rose 3.1% to $ 1.66. The company’s market capitalization is $ 5.8 million.
Losers
- Biogenic The stock (NASDAQ: BIIB) fell 6.8% to $ 225.0 in Tuesday’s after-sales session. This title traded at a volume of 204.7K shares is approaching, representing 14.9% of its average volume over the last 100 days. The market value of their outstanding shares is $ 33.0 billion.
- Amylyx Pharmaceutical (NASDAQ: AMLX) the stock fell 5.38% to $ 19.0. The company’s market capitalization is $ 1.0 billion.
- Pharmaceutical Phio (NASDAQ: PHIO) stocks fell 4.62% to $ 0.98. Trading volume for this security closed at 70.9K, representing 38.2% of its full-day average volume over the past 100 days. The company’s market capitalization is $ 13.2 million.
- Therapeutic relay (NASDAQ: RLAY) the stock fell 4.51% to $ 26.5. At the close, the volume of transactions of Relay Therapeutics reached 145.7K shares. This represents 18.8% of its average volume over the past 100 days. The company’s market capitalization is $ 2.8 billion.
- Voyager Therapeutics (NASDAQ: VYGR) shares fell 4.11% to $ 2.8. The market value of their outstanding shares is $ 106.2 million.
- Medical Travel (NASDAQ: DERM) was down 3.28% to $ 5.32. The market value of their outstanding shares is $ 88.6 million.
See also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga’s automated content engine and edited by an editor.